Vivalto Partners
Vivalto Partners is an independent European private equity management company founded in 2021 and based in Paris, specializing in investments in profitable small and mid-sized companies within the healthcare sector across France and continental Europe. It manages a healthcare-focused fund, Vivalto Capital I, with a target size of around €700 million, supporting companies through capital and strategic and operational assistance.
Vivalto Partners is a Paris buyout firm with €700M AUM and 9 active companies.
Sector breakdown
9 companiesGeography breakdown
2 geographiesKey facts
Recent exits
No exits recorded yet.
Coverage notes
1 fund tracked, 9 portfolio companies (9 active · 0 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Vivalto Partners has raised, with its portfolio companies. Hand-checked from public filings.
Vivalto Partners Fund IinvestingGrowth2024€700M9 assetsGrowth2024 · 2yr€700M9–
Unrealized
9 held| Company | Entry |
|---|---|
| CBA Informatique Liberale HealthTech · France | 2023 |
| Groupe Medical Ovalie Healthcare · France | 2024 |
| Laboratoires Delbert Pharma · France | 2023 |
| Linnea SA Healthcare · Switzerland | 2025 |
| Ophthalmologic Network Organisation Healthcare · Switzerland | 2023 |
| Resilience HealthTech · France | 2022 |
| SFAN Laboratoire Pharma · France | 2025 |
| Tribun Health HealthTech · France | 2019 |
| Vivalto Sante Healthcare · France | 2021 |
About Vivalto Partners
Vivalto Partners is an independent European private equity management company with €700 million of assets under management as of December 2024, founded in 2021 and headquartered in Paris. The firm specialises in investments in profitable small and mid-sized companies within the healthcare sector, with the healthcare-exclusive focus distinguishing Vivalto from generalist mid-cap peers and aligning the platform with the structural growth trends in European healthcare.
Investment thesis
Vivalto targets European small and mid-cap healthcare companies, deploying equity tickets typically ranging from €15 million to €60 million per transaction across both majority and significant minority positions. Sector focus spans the breadth of healthcare verticals including pharma services, medical devices, healthcare services, digital health and selectively biotech businesses. The exclusive healthcare mandate enables deep clinical, regulatory and operational expertise across portfolio companies.
Recent activity
The platform tracks a single dedicated fund vehicle and 7 active portfolio companies across the inaugural deployment of the healthcare-focused PE programme. As a recently established platform (2021 founding), Vivalto is in the active deployment phase with realised exits expected in subsequent years aligned with typical 5-7 year buyout cycles.
Frequently asked questions
- What investment strategy does Vivalto Partners focus on?
- Vivalto Partners focuses on Buyout, Growth strategies in the private equity space.
- How many portfolio companies does Vivalto Partners have?
- Vivalto Partners has 9 active portfolio companies and 1 fund tracked on GP Intel.
- Where is Vivalto Partners headquartered?
- Vivalto Partners is headquartered in Paris, France.
- What is Vivalto Partners's assets under management?
- Vivalto Partners manages approximately €700M in assets under management.
- When was Vivalto Partners founded?
- Vivalto Partners was founded in 2020.
- What sectors does Vivalto Partners invest in?
- Vivalto Partners invests across Healthcare, Business Services.
Similar firms
Other private equity firms tracked on GP Intel.
France·€700M
France·€704M
France·€740M
France·€650M
France·€650M
France·€750M
France·€635M
France·€625M
France·€780M
France·€604M
France·€600M
France·€800M